229 related articles for article (PubMed ID: 21135112)
1. Invasive prostate carcinoma driven by c-Src and androgen receptor synergy.
Cai H; Babic I; Wei X; Huang J; Witte ON
Cancer Res; 2011 Feb; 71(3):862-72. PubMed ID: 21135112
[TBL] [Abstract][Full Text] [Related]
2. Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases.
Liu Y; Karaca M; Zhang Z; Gioeli D; Earp HS; Whang YE
Oncogene; 2010 Jun; 29(22):3208-16. PubMed ID: 20383201
[TBL] [Abstract][Full Text] [Related]
3. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
4. Myristoylation of Src kinase mediates Src-induced and high-fat diet-accelerated prostate tumor progression in mice.
Kim S; Yang X; Li Q; Wu M; Costyn L; Beharry Z; Bartlett MG; Cai H
J Biol Chem; 2017 Nov; 292(45):18422-18433. PubMed ID: 28939770
[TBL] [Abstract][Full Text] [Related]
5. Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells.
Nautiyal J; Banerjee S; Kanwar SS; Yu Y; Patel BB; Sarkar FH; Majumdar AP
Int J Cancer; 2011 Feb; 128(4):951-61. PubMed ID: 20473900
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK.
Lee LF; Louie MC; Desai SJ; Yang J; Chen HW; Evans CP; Kung HJ
Oncogene; 2004 Mar; 23(12):2197-205. PubMed ID: 14767470
[TBL] [Abstract][Full Text] [Related]
7. Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancer.
Yang JC; Ok JH; Busby JE; Borowsky AD; Kung HJ; Evans CP
Cancer Res; 2009 Jan; 69(1):151-60. PubMed ID: 19117998
[TBL] [Abstract][Full Text] [Related]
8. Src signaling pathways in prostate cancer.
Varkaris A; Katsiampoura AD; Araujo JC; Gallick GE; Corn PG
Cancer Metastasis Rev; 2014 Sep; 33(2-3):595-606. PubMed ID: 24522479
[TBL] [Abstract][Full Text] [Related]
9. Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells.
Nam S; Kim D; Cheng JQ; Zhang S; Lee JH; Buettner R; Mirosevich J; Lee FY; Jove R
Cancer Res; 2005 Oct; 65(20):9185-9. PubMed ID: 16230377
[TBL] [Abstract][Full Text] [Related]
10. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
Axlund SD; Lambert JR; Nordeen SK
Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
[TBL] [Abstract][Full Text] [Related]
11. High-Content Screening Identifies Src Family Kinases as Potential Regulators of AR-V7 Expression and Androgen-Independent Cell Growth.
Szafran AT; Stephan C; Bolt M; Mancini MG; Marcelli M; Mancini MA
Prostate; 2017 Jan; 77(1):82-93. PubMed ID: 27699828
[TBL] [Abstract][Full Text] [Related]
12. Src controls castration recurrence of CWR22 prostate cancer xenografts.
Su B; Gillard B; Gao L; Eng KH; Gelman IH
Cancer Med; 2013 Dec; 2(6):784-92. PubMed ID: 24403252
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase.
Zarif JC; Lamb LE; Schulz VV; Nollet EA; Miranti CK
Oncotarget; 2015 Mar; 6(9):6862-76. PubMed ID: 25730905
[TBL] [Abstract][Full Text] [Related]
14. Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells.
Asim M; Siddiqui IA; Hafeez BB; Baniahmad A; Mukhtar H
Oncogene; 2008 Jun; 27(25):3596-604. PubMed ID: 18223692
[TBL] [Abstract][Full Text] [Related]
15. Effects of dasatinib on SRC kinase activity and downstream intracellular signaling in primitive chronic myelogenous leukemia hematopoietic cells.
Konig H; Copland M; Chu S; Jove R; Holyoake TL; Bhatia R
Cancer Res; 2008 Dec; 68(23):9624-33. PubMed ID: 19047139
[TBL] [Abstract][Full Text] [Related]
16. Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival.
Shor AC; Keschman EA; Lee FY; Muro-Cacho C; Letson GD; Trent JC; Pledger WJ; Jove R
Cancer Res; 2007 Mar; 67(6):2800-8. PubMed ID: 17363602
[TBL] [Abstract][Full Text] [Related]
17. Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo.
Goc A; Al-Husein B; Katsanevas K; Steinbach A; Lou U; Sabbineni H; DeRemer DL; Somanath PR
Oncotarget; 2014 Feb; 5(3):775-87. PubMed ID: 24519956
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase.
Lee LF; Guan J; Qiu Y; Kung HJ
Mol Cell Biol; 2001 Dec; 21(24):8385-97. PubMed ID: 11713275
[TBL] [Abstract][Full Text] [Related]
19. The role of Src in prostate cancer.
Fizazi K
Ann Oncol; 2007 Nov; 18(11):1765-73. PubMed ID: 17426060
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]